Exhibit 23.2
CONSENT OF INDEPENDENT AUDITORS
We consent to the use in this Registration Statement on Form F-1 of our report dated February 18, 2020 relating to the financial statements of Aegerion Pharmaceuticals, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
January 8, 2021
